Danrui Cui

866 total citations
27 papers, 655 citations indexed

About

Danrui Cui is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Danrui Cui has authored 27 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Danrui Cui's work include Ubiquitin and proteasome pathways (16 papers), Cancer-related Molecular Pathways (12 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Danrui Cui is often cited by papers focused on Ubiquitin and proteasome pathways (16 papers), Cancer-related Molecular Pathways (12 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Danrui Cui collaborates with scholars based in China, Madagascar and United States. Danrui Cui's co-authors include Yongchao Zhao, Xiufang Xiong, Xiaoyu Chen, Shanshan Gu, Jianfeng Shu, Yanli Bi, Yi Sun, Xiao-Qing Dai, Ying Ma and Dian Liu and has published in prestigious journals such as The Science of The Total Environment, Oncogene and The FASEB Journal.

In The Last Decade

Danrui Cui

23 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danrui Cui China	14	563	220	110	92	56	27	655
Olaf Klingbeil United States	12	425 0.8×	316 1.4×	152 1.4×	118 1.3×	28 0.5×	17	685
Ernest Medina United States	6	444 0.8×	160 0.7×	160 1.5×	80 0.9×	101 1.8×	9	607
Julia M. Fraile Spain	7	616 1.1×	209 0.9×	129 1.2×	100 1.1×	66 1.2×	8	733
Carol F. Franks United States	8	425 0.8×	209 0.9×	111 1.0×	144 1.6×	50 0.9×	10	640
Sudha Mannava United States	9	631 1.1×	207 0.9×	44 0.4×	201 2.2×	67 1.2×	11	757
Seemana Bhattacharya United States	11	402 0.7×	168 0.8×	56 0.5×	47 0.5×	30 0.5×	23	483
Marie‐France Gaumont‐Leclerc Canada	10	668 1.2×	247 1.1×	49 0.4×	136 1.5×	63 1.1×	11	883
Eun Ryoung Jang United States	16	506 0.9×	231 1.1×	70 0.6×	50 0.5×	47 0.8×	24	657
Antonio Lucena-Cacace Spain	14	365 0.6×	261 1.2×	78 0.7×	104 1.1×	33 0.6×	23	598
Nathiya Muthalagu United Kingdom	5	564 1.0×	161 0.7×	102 0.9×	168 1.8×	71 1.3×	8	693

Countries citing papers authored by Danrui Cui

Since Specialization

Citations

This map shows the geographic impact of Danrui Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danrui Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danrui Cui more than expected).

Fields of papers citing papers by Danrui Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danrui Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danrui Cui. The network helps show where Danrui Cui may publish in the future.

Co-authorship network of co-authors of Danrui Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Danrui Cui. A scholar is included among the top collaborators of Danrui Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danrui Cui. Danrui Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cui, Danrui, Xiaoyu Chen, Xue Liang, et al.. (2025). The Crosstalk Between CRL5 and APC/C E3 Ligases Regulates Metastasis and Chemosensitivity of Cancer Cells. Advanced Science. 13(3). e12652–e12652.

Cui, Danrui, et al.. (2025). WSB2 inhibits apoptosis and autophagy by targeting NOXA for degradation. MedComm. 6(2). e70071–e70071. 1 indexed citations

Cui, Danrui, Xiaoyu Chen, Wenfeng Song, et al.. (2025). The FBXW7‐RPAP2 Axis Controls the Growth of Hepatocellular Carcinoma Cells and Determines the Fate of Liver Cell Differentiation. Advanced Science. 12(13). e2404718–e2404718. 3 indexed citations

Jiang, Yizhou, et al.. (2025). Environmental impact analysis of biomass straw substituting coal in the rural building heating sector. The Science of The Total Environment. 990. 179890–179890.

Chen, Xiaoyu, Yu‐Ying Lu, Ying Ma, et al.. (2025). UBE2C promotes pancreatic tumorigenesis by KRAS stabilization via APC/CCDH1-mediated WDR76 degradation. Cancer Letters. 633. 218013–218013.

Xiong, Xiufang, Xiaoyu Chen, Danrui Cui, et al.. (2025). DEPTOR suppresses lymphomagenesis by promoting EGFR degradation via HUWE1 E3 ligase. Cell Death and Differentiation. 32(10). 1820–1832. 1 indexed citations

Liang, Xue, Danrui Cui, Yanning Liu, et al.. (2023). The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway. Cell Death and Differentiation. 30(6). 1550–1562. 24 indexed citations

Cui, Danrui, Dian Liu, Xiao Z. Shen, et al.. (2022). FBXW7 inactivation induces cellular senescence via accumulation of p53. Cell Death and Disease. 13(9). 788–788. 13 indexed citations

Cui, Danrui, et al.. (2021). The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses. Frontiers in Cell and Developmental Biology. 9. 775507–775507. 55 indexed citations

10.

Shu, Jianfeng, Xiaoyu Chen, Hui Pan, et al.. (2021). DEPTOR inhibits lung tumorigenesis by inactivating the EGFR-mTOR signals. Cancer Letters. 519. 263–276. 13 indexed citations

11.

Shu, Jianfeng, Danrui Cui, Ying Ma, et al.. (2020). SCFβ-TrCP-mediated degradation of TOP2β promotes cancer cell survival in response to chemotherapeutic drugs targeting topoisomerase II. Oncogenesis. 9(2). 8–8. 14 indexed citations

12.

Cui, Danrui, et al.. (2020). Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs. Advances in experimental medicine and biology. 1217. 317–347. 10 indexed citations

13.

Cui, Danrui, Xiufang Xiong, Jianfeng Shu, et al.. (2020). FBXW7 Confers Radiation Survival by Targeting p53 for Degradation. Cell Reports. 30(2). 497–509.e4. 65 indexed citations

14.

Cui, Danrui, et al.. (2020). DEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity. Cell Death and Disease. 11(11). 976–976. 15 indexed citations

15.

Xiong, Xiufang, Danrui Cui, Yanli Bi, Yi Sun, & Yongchao Zhao. (2020). Neddylation modification of ribosomal protein RPS27L or RPS27 by MDM2 or NEDP1 regulates cancer cell survival. The FASEB Journal. 34(10). 13419–13429. 12 indexed citations

16.

Cui, Danrui, Xiao-Qing Dai, Jianfeng Shu, et al.. (2019). The cross talk of two family members of β-TrCP in the regulation of cell autophagy and growth. Cell Death and Differentiation. 27(3). 1119–1133. 38 indexed citations

17.

Chen, Xiaoyu, Xiufang Xiong, Danrui Cui, et al.. (2019). DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 39(7). 1557–1571. 36 indexed citations

18.

Chen, Xiaoyu, Danrui Cui, Yanli Bi, et al.. (2018). AKT inhibitor MK-2206 sensitizes breast cancer cells to MLN4924, a first-in-class NEDD8-activating enzyme (NAE) inhibitor. Cell Cycle. 17(16). 2069–2079. 20 indexed citations

19.

Wang, Jingchao, Danrui Cui, Shanshan Gu, et al.. (2018). Autophagy regulates apoptosis by targeting NOXA for degradation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(8). 1105–1113. 23 indexed citations

20.

Cui, Danrui, Xiufang Xiong, & Yongchao Zhao. (2016). Cullin-RING ligases in regulation of autophagy. Cell Division. 11(1). 8–8. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact